cerrar
Tagged with

Andreu Mas-Colell – President, BIST, Spain
Andreu Mas-Colell, former minister of finance for Catalonia and president of the Barcelona Institute of Science and Technology (BIST), discusses the…

Christoph Heider – President, ECCK, South Korea
Christoph Heider, president of the European Chamber of Commerce in Korea (ECCK), discusses the organization, the need for the modernization of the…

Gérard Raymond – President, FFD, France
Gérard Raymond, president of the Fédération Francaise des Diabétiques (FFD - French Diabetes Federation), gives an update on the situation of…

The Line Manager of Tomorrow
Ian Chamberlain looks at the changing role of the pharma sales manager and the skills needed to keep up with new tech and the next generation of…

Gene-modified Babies in China Highlight Regulatory Concerns of…
Aditya Bhattacharji manages Eurasia Group‘s healthcare analysis and Kevin Allison is the director of geo-technology. Together they look at last…

Spanish Government Moves to Ban Pseudo-therapies
According to a survey carried out by the Spanish Foundation for Science and Technology (FECYT) over half of the Spanish population believe…

Sherene Azli – CEO, MHTC, Malaysia
Sherene Azli, CEO of the Malaysia Healthcare Travel Council (MHTC), introduces this unique organization in charge of promoting Malaysia…

Şekib Avdagiç – President, Istanbul Chamber of Commerce;…
Şekib Avdagiç, president of the Istanbul Chamber of Commerce and Istanbul Convention and Visitors Bureau (ICVB) provides an in-depth analysis of the…

Rashidah Ibrahim – Executive Director, MVP, Malaysia
Rashidah Ibrahim, executive director of Malaysian Vaccines & Pharmaceuticals (MVP), tells the story of MVP as the sole animal vaccines…

Novartis’ M&A Saga and What it Could Mean for Sandoz
Christoph Bieri, PhD is Managing Partner of Kurmann Partners, an M&A firm advising Pharma and MedTech companies on strategic mid-market deals in…

Digital and Advanced Analytics: From Hype to Tipping Point in…
Martin Dewhurst, co-leader for McKinsey’s global Pharmaceuticals and Medical Products Practice, discusses the enormous potential value of digital…

The NFL’s Opioid Crisis: Is Cannabis the Answer?
With an increasing number of NFL players relying on potentially dangerous prescription painkillers, does the league need to relax its attitude to…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here